Almagate: Difference between revisions
(Created page with "{{Drugbox | verifiedrevid = 443400546 | IUPAC_name = | image = <!--Almagate.svg--> <!--Clinical data--> | tradename = | Drugs.com = {{drugs.com|international|almagate}} |...") |
No edit summary |
||
| Line 50: | Line 50: | ||
| StdInChIKey = MTEOMEWVDVPTNN-UHFFFAOYSA-E | | StdInChIKey = MTEOMEWVDVPTNN-UHFFFAOYSA-E | ||
}} | }} | ||
__NOTOC__ | |||
{{SI}} | |||
{{CMG}} | |||
==Overview== | |||
'''Almagate''' (trade name '''Almax''') is an [[aluminium]]- and [[magnesium]]-containing [[antacid]]. It was first described in 1984.<ref>{{cite pmid|6548918}}</ref><ref>{{cite pmid|6439224}}</ref> | '''Almagate''' (trade name '''Almax''') is an [[aluminium]]- and [[magnesium]]-containing [[antacid]]. It was first described in 1984.<ref>{{cite pmid|6548918}}</ref><ref>{{cite pmid|6439224}}</ref> | ||
| Line 56: | Line 62: | ||
== References == | == References == | ||
{{Reflist}} | {{Reflist|2}} | ||
{{Antacids}} | {{Antacids}} | ||
[[Category: | [[Category:Drug]] | ||
[[Category:Aluminium compounds]] | [[Category:Aluminium compounds]] | ||
[[Category:Magnesium compounds]] | [[Category:Magnesium compounds]] | ||
Revision as of 15:28, 13 April 2015
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| Routes of administration | Oral |
| ATC code | |
| Identifiers | |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | Al2Mg6(OH)14(CO3)2 · 4 H2O |
| Molar mass | 314.99 g/mol |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
|
WikiDoc Resources for Almagate |
|
Articles |
|---|
|
Most recent articles on Almagate |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Almagate at Clinical Trials.gov Clinical Trials on Almagate at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Almagate
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Directions to Hospitals Treating Almagate Risk calculators and risk factors for Almagate
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Almagate |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Almagate (trade name Almax) is an aluminium- and magnesium-containing antacid. It was first described in 1984.[1][2]
Adverse effects
Almagate is well tolerated. In a clinical trial, the most common adverse effects were diarrhea and nausea.[3]
References
- ↑ PMID 6548918 (PMID 6548918)
Citation will be completed automatically in a few minutes. Jump the queue or expand by hand - ↑ PMID 6439224 (PMID 6439224)
Citation will be completed automatically in a few minutes. Jump the queue or expand by hand - ↑ PMID 6548926 (PMID 6548926)
Citation will be completed automatically in a few minutes. Jump the queue or expand by hand
- Pages with script errors
- Pages with incomplete PMID references
- Template:drugs.com link with non-standard subpage
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Infobox drug articles without a structure image
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Drugs with no legal status
- Drug
- Aluminium compounds
- Magnesium compounds